Fig. 4From: Integrated structure model-based virtual screening approaches identified anti-cancer agents against prostate cancer by targeting MAOB proteinThe ability of the structure-based pharmacophore model to find both active and decoy compounds allowed for the creation of a receiver operating characteristic (ROC) curve. Twenty MAOB actives and six hundred inactive compounds were used to test the pharmacophore modelBack to article page